Charat Thongprayoon1, Wisit Cheungpasitporn2, Panupong Hansrivijit3, Sorkko Thirunavukkarasu1, Api Chewcharat1, Juan Medaura2, Michael A Mao4, Kianoush Kashani5. 1. Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic Rochester, Rochester, Minnesota, USA. 2. Division of Nephrology, Department of Internal Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA. 3. Department of Internal Medicine, UPMC Pinnacle Harrisburg, Harrisburg, Pennsylvania, USA. 4. Division of Nephrology and Hypertension, Mayo Clinic Florida, Jacksonville, Florida, USA. 5. Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic Rochester, Rochester, Minnesota, USA kashani.kianoush@mayo.edu.
Authors: Charat Thongprayoon; Yeshwanter Radhakrishnan; Wisit Cheungpasitporn; Tananchai Petnak; Jose Zabala Genovez; Api Chewcharat; Fawad Qureshi; Michael A Mao; Kianoush B Kashani Journal: J Nephrol Date: 2022-03-26 Impact factor: 3.902
Authors: Fatma I Albeladi; Iman M Wahby Salem; Albandari A Albandar; Hamidah A Almusaylim; Ali S Albandar Journal: J Taibah Univ Med Sci Date: 2021-11-20